YUVIWEL Trademark

Trademark Overview


On Monday, June 24, 2024, a trademark application was filed for YUVIWEL with the United States Patent and Trademark Office. The USPTO has given the YUVIWEL trademark a serial number of 98615005. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Monday, June 24, 2024. This trademark is owned by Ascendis Pharma Growth Disorders A/S. The YUVIWEL trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

Pharmaceutical preparations for the treatment of growth disorders; pharmaceutical preparations for the treatment of endocrine disorders; pharmaceutical preparations for the treatment of bone disorders; pharmaceutical preparations for the treatment of skeletal disorders; pharmaceutical preparations for the treatment of genetic disorders affecting bone and skeletal growth; pharmaceutical preparations for the treatment of osteochondrodysplasia, achondroplasia and hypochondroplasia; diagnostic preparations for medical use, namely, diagnostic preparations for identifying and detecting growth disorders, endocrine disorders, bone disorders, skeletal disorders, osteochondrodysplasia, achondroplasia and hypochondroplasia

Medical devices for injection, dosage and control of pharmaceuticals, namely medical devices for injection, dosage and control of pharmaceuticals for the treatment of growth disorders, endocrine disorders, bone disorders, skeletal disorders, osteochondrodysplasia, achondroplasia and hypochondroplasia; medical devices for dosage and injection of pharmaceutical and medical preparations, namely pen-type syringes, medical auto-injectors, autoinjector syringes, injection needles, and autoinjector cartridges; Syringes for medical purposes and for injections; Syringes for injection for medical use, namely syringes in the form of pens for medical and surgical use; Digitally connected medical devices for monitoring the dispensation of pharmaceutical preparations for use in connection with management of skeletal disorders, osteochondrodysplasia, achondroplasia and hypochondroplasia; Medical apparatus, namely, infusion and injection devices for administering drugs; Apparatus and instruments for d...
yuviwel

General Information


Serial Number98615005
Word MarkYUVIWEL
Filing DateMonday, June 24, 2024
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateMonday, June 24, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of growth disorders; pharmaceutical preparations for the treatment of endocrine disorders; pharmaceutical preparations for the treatment of bone disorders; pharmaceutical preparations for the treatment of skeletal disorders; pharmaceutical preparations for the treatment of genetic disorders affecting bone and skeletal growth; pharmaceutical preparations for the treatment of osteochondrodysplasia, achondroplasia and hypochondroplasia; diagnostic preparations for medical use, namely, diagnostic preparations for identifying and detecting growth disorders, endocrine disorders, bone disorders, skeletal disorders, osteochondrodysplasia, achondroplasia and hypochondroplasia
Goods and ServicesMedical devices for injection, dosage and control of pharmaceuticals, namely medical devices for injection, dosage and control of pharmaceuticals for the treatment of growth disorders, endocrine disorders, bone disorders, skeletal disorders, osteochondrodysplasia, achondroplasia and hypochondroplasia; medical devices for dosage and injection of pharmaceutical and medical preparations, namely pen-type syringes, medical auto-injectors, autoinjector syringes, injection needles, and autoinjector cartridges; Syringes for medical purposes and for injections; Syringes for injection for medical use, namely syringes in the form of pens for medical and surgical use; Digitally connected medical devices for monitoring the dispensation of pharmaceutical preparations for use in connection with management of skeletal disorders, osteochondrodysplasia, achondroplasia and hypochondroplasia; Medical apparatus, namely, infusion and injection devices for administering drugs; Apparatus and instruments for diagnostic purposes, namely, dosage management dispensers for medicines containing software for medical information management for use in web-based physical and psychological examination and assessment of patients remotely and at a clinic; Dosage management dispensers containing software for medical information management for guidance and control of medicines and for therapeutic use in web-based physical and psychological examination and assessment of patients remotely and at a clinic

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, June 24, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateMonday, June 24, 2024
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAscendis Pharma Growth Disorders A/S
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressHellerup 2900
DK

Trademark Events


Event DateEvent Description
Monday, June 24, 2024NEW APPLICATION ENTERED
Monday, June 24, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED